Dina Labib
Overview
Explore the profile of Dina Labib including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Labib D, Haykowsky M, Sonnex E, Mackey J, Thompson R, Paterson D, et al.
Cardiooncology
. 2025 Feb;
11(1):13.
PMID: 39923094
Background: This study investigates the long-term cardiac effects of trastuzumab-based chemotherapy in early breast cancer (EBC) survivors. We extend the original MANTICORE trial which showed that angiotensin-converting enzyme inhibitors (ACEI)...
2.
Dykstra S, MacDonald M, Beaudry R, Labib D, King M, Feng Y, et al.
NPJ Digit Med
. 2025 Feb;
8(1):84.
PMID: 39910290
Coordinated access to multi-domain health data can facilitate the development and implementation of artificial intelligence-augmented clinical decision support (AI-CDS). However, scalable institutional frameworks supporting these activities are lacking. We present...
3.
Rabbani M, Hassanabad A, Satriano A, Labib D, Lydell C, Bristow M, et al.
Can J Cardiol
. 2024 Dec;
PMID: 39667492
Background: Multiphase computed tomography angiography (mpCTA) is routinely performed prior to transcatheter aortic valve replacement (TAVR) to determine eligibility and enable preprocedural planning. Incremental prognostic value may be realized from...
4.
Hillier E, Elharram M, White J, Anderson T, Luu J, Labib D, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Mar;
25(8):1136-1143.
PMID: 38546135
Aims: Women with angina and non-obstructive coronary artery disease (ANOCA) have a heightened risk for cardiovascular events, and the pathophysiology for ischaemic symptoms may be related to alterations in microvascular...
5.
Mallabone M, Labib D, Abdelhaleem A, Dykstra S, Thompson R, Paterson D, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jan;
25(6):804-813.
PMID: 38236156
Aims: We sought to characterize sex-related differences in cardiovascular magnetic resonance-based cardiovascular phenotypes and prognosis in patients with idiopathic non-ischaemic cardiomyopathy (NICM). Methods And Results: Patients with NICM enrolled in...
6.
Kashyap N, Nikhanj A, Labib D, Prosia E, Rivest S, Flewitt J, et al.
J Am Heart Assoc
. 2023 Nov;
12(21):e030229.
PMID: 37929714
Background The prognostic utility of cardiovascular magnetic resonance imaging, including strain analysis and tissue characterization, has not been comprehensively investigated in adult patients with muscular dystrophy. Methods and Results We...
7.
Ballantyne B, Vandenberk B, Dykstra S, Labib D, Chew D, Lydell C, et al.
Int J Cardiovasc Imaging
. 2023 Jul;
39(10):2005-2014.
PMID: 37421578
Purpose: While implantable cardioverter-defibrillator (ICD) therapy provides clear benefit in patients with ischemic cardiomyopathy (ICM), this is less clear in patients with non-ischemic cardiomyopathy (NICM). Mid-wall striae (MWS) fibrosis is...
8.
Guzzardi D, White J, Labib D, Dykstra S, Flewitt J, Feuchter P, et al.
Int J Cardiovasc Imaging
. 2023 Jan;
39(1):115-134.
PMID: 36598686
3-Dimensional (3D) myocardial deformation analysis (3D-MDA) enables novel descriptions of geometry-independent principal strain (PS). Applied to routine 2D cine cardiovascular magnetic resonance (CMR), this provides unique measures of myocardial biomechanics...
9.
Dykstra S, Satriano A, Cornhill A, Lei L, Labib D, Mikami Y, et al.
Front Cardiovasc Med
. 2022 Oct;
9:998558.
PMID: 36247426
Background: Atrial fibrillation (AF) is a commonly encountered cardiac arrhythmia associated with morbidity and substantial healthcare costs. While patients with cardiovascular disease experience the greatest risk of new-onset AF, no...
10.
Yakimenka A, Labib D, Dykstra S, Mikami Y, Satriano A, Flewitt J, et al.
Front Cardiovasc Med
. 2022 Aug;
9:894592.
PMID: 35966521
Background: Pulmonary vein isolation (PVI) is a commonly engaged therapy for symptomatic atrial fibrillation (AF). Prior studies have documented elevated AF recurrence rates among females vs. males. Sex-specific mechanisms underlying...